These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6244111)

  • 41. Morphological transformation of cells induced by Kirsten sarcoma virus transforming factor is independent of serine proteases.
    Fulton RJ; Kaplan PL; Hart DA; Ozanne B
    J Cell Physiol; 1982 Jan; 110(1):81-3. PubMed ID: 6279679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Involvement of reactive oxygen intermediates in the mutagenicity of tumor promoters.
    Biggart NW; Murphy EC
    Basic Life Sci; 1988; 49():457-60. PubMed ID: 2854992
    [No Abstract]   [Full Text] [Related]  

  • 43. [The suppression of osteogenic differentiation markers in human osteosarcoma cells transformed by Kirsten murine sarcoma virus].
    Katayama N
    Kokubyo Gakkai Zasshi; 1988 Dec; 55(4):585-98. PubMed ID: 2855077
    [No Abstract]   [Full Text] [Related]  

  • 44. Inhibition of epidermal growth factor binding to surface receptors by tumor promotors.
    Brown KD; Dicker P; Rozengurt E
    Biochem Biophys Res Commun; 1979 Feb; 86(4):1037-43. PubMed ID: 312103
    [No Abstract]   [Full Text] [Related]  

  • 45. Epidermal growth factor and tumor promoters prevent DNA fragmentation by different mechanisms.
    Kanter P; Leister KJ; Tomei LD; Wenner PA; Wenner CE
    Biochem Biophys Res Commun; 1984 Jan; 118(2):392-9. PubMed ID: 6608349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retinoids as well as tumour promoters enhance deacylation of cellular lipids and prostaglandin production in MDCK cells.
    Levine L; Ohuchi K
    Nature; 1978 Nov; 276(5685):274-5. PubMed ID: 714157
    [No Abstract]   [Full Text] [Related]  

  • 47. Promotion of x-ray transformation in vitro.
    Little JB; Kennedy AR
    Carcinog Compr Surv; 1982; 7():243-57. PubMed ID: 6978179
    [No Abstract]   [Full Text] [Related]  

  • 48. Cell cycle-specific inhibition by retinoic acid of xenotropic murine retrovirus expression.
    Suk WA; Ceccorulli LM; Long CW
    Cancer Res; 1981 Mar; 41(3):1045-50. PubMed ID: 6161694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition by retinoic acid of murine retrovirus-induced cellular transformation and tumor formation.
    Giese NA; Neary KE; Levine N; Lindell TJ; Duffy JJ
    J Natl Cancer Inst; 1985 May; 74(5):1135-44. PubMed ID: 2987593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutants of nonproducer cell lines transformed by murine sarcoma virus. IV. Multiplicity of proviral sequences and persistent viral production.
    Hatanaka M; Okabe H
    Intervirology; 1983; 19(3):149-54. PubMed ID: 6299995
    [No Abstract]   [Full Text] [Related]  

  • 51. The modulation of growth of normal rat liver epithelial cells in calcium-poor medium by epidermal growth factor, phenobarbital, phorbol ester, and retinoic acid.
    Tsao MS; Smith JD; Grisham JW
    In Vitro Cell Dev Biol; 1985 May; 21(5):249-53. PubMed ID: 3874861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation by normal serum factors of Kirsten murine sarcoma virus-induced transformation in adult rat cells infected in early passage.
    Auersperg N; Siemens CH; Krystal G; Myrdal SE
    Cancer Res; 1986 Nov; 46(11):5715-23. PubMed ID: 3019533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sodium-n-butyrate induces secretion and substrate accumulation of p52 in Kirsten sarcoma virus-transformed rat kidney fibroblasts.
    Ryan MP; Higgins PJ
    Int J Biochem; 1989; 21(1):31-7. PubMed ID: 2546834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of viruses with tumor promotors.
    Yamamoto N
    Rev Physiol Biochem Pharmacol; 1984; 101():111-59. PubMed ID: 6097985
    [No Abstract]   [Full Text] [Related]  

  • 55. Diverse effects: augmentation, inhibition, and non-efficacy of 12-O-tetradecanoylphorbol-13-acetate (TPA) on retrovirus genome expression in vivo and in vitro.
    Lipp M; Scherer B; Lips G; Brandner G; Hunsmann G
    Carcinogenesis; 1982; 3(3):261-5. PubMed ID: 6177439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Guanine nucleotide binding activity of the src gene product of rat-derived murine sarcoma viruses.
    Scolnick EM; Shih TY; Maryak J; Ellis R; Chang E; Lowy D
    Ann N Y Acad Sci; 1980; 354():398-409. PubMed ID: 6261655
    [No Abstract]   [Full Text] [Related]  

  • 57. Inhibition by tumor-promoting phorbol esters of procollagen synthesis in promotable JB6 mouse epidermal cells.
    Dion LD; Bear J; Bateman J; De Luca LM; Colburn NH
    J Natl Cancer Inst; 1982 Nov; 69(5):1147-54. PubMed ID: 6957659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of induced murine erythroleukemia cell differentiation by tumor promoters: relation to the cell cycle.
    Gambari R; Fibach E; Rifkind RA; Marks PA
    Biochem Biophys Res Commun; 1980 Jun; 94(3):867-74. PubMed ID: 7396937
    [No Abstract]   [Full Text] [Related]  

  • 59. Inhibition of induced differentiation of C3H/10T 1/2 clone 8 mouse embryo cells by tumor promoters.
    Mondal S; Heidelberger C
    Cancer Res; 1980 Feb; 40(2):334-8. PubMed ID: 6153153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transformation of MMC-E epithelial cells by acute 3611-MSV: inhibition of collagen synthesis and induction of novel polypeptides.
    Keski-Oja J; Rapp UR; Vaheri A
    J Cell Biochem; 1982; 20(2):139-48. PubMed ID: 6302114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.